Vitiligo
Conditions
Interventions
A:topical corticosteroid as 0.05% clobetasol propionate cream in isopropyl alcohol 65o preparation (in equal proportion) for the body and 0.1% triamcinolone acetonide cream for the face and flexures,
B:topical corticosteroid (compatible with the first group) admixed with oral zinc sulfate (220-mg capsule) in dose of 2 capsules per day in teenager and adults and 10mg/kg of capsule or syrup for chil
. For the second group, serum zinc level was repeatedly measured 1 and 3 months after commencing the treatment.
Sponsors
Jundishapour University of Medical Sciences, Ahvaz, Iran
Eligibility
Sex/Gender
All
Age
11 Years to 59 Years
Inclusion criteria
Inclusion criteria: Any ageAny gender The localized and gneralized types of vitiligo with exception of segmental one (with involvement <20% of body surface)Vitiligo duration less than 5 yearsNegative history of systemic disorderNo pregnancyNegative history of drug administrationNormal or low serum zincNormal other laboratory testsTaking no zinc during 4 weeks prior to referring
Exclusion criteria
Exclusion criteria: The segmental and universal types of vitiligo Positve history of systemic disorder Pregnancy Positive history of drug administration High serum zinc Abnormal other laboratory tests Taking zinc during 4 weeks prior to referring
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical Examination;Vitiligo data;The results of treatment;Past history;Demographic data;Data of the two study groups;Laboratory test; | — |
Countries
Iran
Contacts
Public ContactReza Yaghoobi
Outcome results
None listed